12-40105321-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000280871.9(SLC2A13):c.488C>T(p.Ala163Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000238 in 1,598,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000280871.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A13 | NM_052885.4 | c.488C>T | p.Ala163Val | missense_variant | 1/10 | ENST00000280871.9 | NP_443117.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A13 | ENST00000280871.9 | c.488C>T | p.Ala163Val | missense_variant | 1/10 | 1 | NM_052885.4 | ENSP00000280871 | P1 | |
SLC2A13 | ENST00000380858.1 | c.488C>T | p.Ala163Val | missense_variant | 1/4 | 1 | ENSP00000370239 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000143 AC: 3AN: 210082Hom.: 0 AF XY: 0.0000258 AC XY: 3AN XY: 116298
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1446442Hom.: 0 Cov.: 32 AF XY: 0.0000139 AC XY: 10AN XY: 718616
GnomAD4 genome AF: 0.000131 AC: 20AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.488C>T (p.A163V) alteration is located in exon 1 (coding exon 1) of the SLC2A13 gene. This alteration results from a C to T substitution at nucleotide position 488, causing the alanine (A) at amino acid position 163 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at